Alzamend Neuro, Inc
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company based in Atlanta, GA, dedicated to developing innovative treatments for Alzheimer's disease, bipolar disorder, major depressive disorder, and post-traumatic stress disorder. Their current product pipeline features two novel drug candidates, AL001 and ALZN002, which are focused on addressing the needs of millions affected by these debilitating conditions.
Committed to rapid development and marketing of safe and effective therapies, Alzamend Neuro leverages exclusive worldwide licenses from the University of South Florida Research Foundation. With a mission to improve the lives of approximately 43 million Americans suffering from these diseases, the company emphasizes the importance of research as a foundation for genuine innovation in treatment.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.